Gufic BioSciences logo

Gufic BioSciences

GUFICBIO NSE

Key Fundamentals

MicrocapPharmaceuticalsHealthcare
Market Cap
₹4,244 Cr
Volatility
Moderate
P/E Ratio
57.99
EBITDA
₹154 Cr
Return on Equity
9.66%
Debt to Equity
0.61
Book Value
₹66.31
EPS
₹8.59
52W High
₹467.8
52W Low
₹268

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Weaknesses

3
  • Stock is trading at 6.42 times its book value
  • Company has a low return on equity of 13.5% over last 3 years.
  • Dividend payout has been low at 1.40% of profits over last 3 years

Growth Rate

Revenue Growth
14.97% higher than 3Y
Net Income Growth
-7.76% lower than 3Y
Cash Flow Change
-63.17% lower than 3Y
ROE
-16.65% lower than 3Y
ROCE
-1.58% higher than 3Y
EBITDA Margin (Avg.)
-4.12% higher than 3Y

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
195
215
202
195
203
204
208
205
227
230
231
252
261
Expenses
160
176
165
161
167
166
174
178
195
195
195
206
214
Operating Profit
35
39
36
34
36
39
34
27
32
36
36
46
47
OPM %
18%
18%
18%
18%
18%
19%
16%
13%
14%
16%
16%
18%
18%
Other Income
1
0
0
1
1
0
2
0
1
2
1
-1
0
Interest
4
4
3
4
5
5
5
8
9
10
8
9
9
Depreciation
4
4
4
4
4
4
5
8
8
8
8
8
8
PBT
28
31
30
27
28
29
26
11
16
21
21
28
30
Tax %
26%
25%
25%
26%
26%
26%
26%
26%
26%
27%
26%
26%
26%
Net Profit
21
23
22
20
21
22
19
8
12
15
16
21
22
EPS in Rs
2.13
2.39
2.22
2
2.08
2.17
1.93
0.79
1.2
1.49
1.55
2.05
2.24
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
148
201
245
306
351
379
488
779
691
807
820
940
974
Expenses
134
181
222
267
305
327
404
631
556
657
683
790
810
Operating Profit
14
20
23
39
46
52
84
148
135
150
136
150
165
OPM %
10%
10%
9%
13%
13%
14%
17%
19%
20%
19%
17%
16%
17%
Other Income
1
1
1
4
4
6
4
3
3
0
4
3
2
Interest
4
6
6
9
10
14
14
5
8
17
25
37
37
Depreciation
4
4
4
4
5
14
16
19
22
17
21
31
31
PBT
7
10
14
30
35
30
58
127
107
116
94
85
99
Tax %
36%
29%
37%
45%
38%
25%
23%
24%
25%
26%
26%
26%
—
Net Profit
4
7
9
16
22
23
44
96
80
86
70
63
74
EPS in Rs
0.54
0.95
1.17
2.13
2.82
2.92
5.68
9.89
8.22
8.59
6.97
6.3
7.33
Div. Payout %
9%
5%
4%
2%
2%
2%
2%
1%
1%
1%
1%
2%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
8
8
8
8
8
10
10
10
10
10
10
10
Reserves
19
26
30
46
68
120
164
259
338
523
591
654
Borrowings
33
43
57
80
98
126
62
64
334
333
336
405
Other Liabilities
67
75
84
104
106
152
157
188
179
227
232
273
Total Liabilities
127
152
178
238
280
408
392
521
861
1,093
1,170
1,342
Fixed Assets
25
22
22
23
24
83
100
115
160
159
506
491
CWIP
0
0
0
2
10
31
13
41
170
307
22
22
Investments
0
0
0
0
0
0
0
0
1
2
3
3
Other Assets
102
130
156
213
245
294
279
365
531
625
639
826
Total Assets
127
152
178
238
280
408
392
521
861
1,093
1,170
1,342
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
11
-4
-4
-5
5
47
87
106
-27
-7
123
44
Investing
-2
-1
-5
-9
-13
-43
-7
-95
-191
-102
-72
-31
Financing
-5
5
7
14
8
-4
-79
-6
234
82
-37
32
Net Cash Flow
4
0
-1
1
0
0
2
5
17
-27
14
45
Free Cash Flow
9
-5
-8
-13
-8
7
75
19
-214
-116
52
13
CFO/OP
92
-8
2
30
33
110
115
94
1
13
107
37
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
82
102
78
97
107
103
93
71
109
149
140
115
Inventory Days
165
180
190
238
190
249
138
102
202
188
211
281
Days Payable
223
188
132
192
157
238
162
125
143
156
155
173
Cash Conversion Cycle
25
94
136
143
141
114
69
48
167
181
197
224
Working Capital Days
4
18
14
26
40
17
63
50
68
97
93
81
ROCE %
18%
24%
24%
33%
30%
21%
29%
46%
23%
17%
13%
12%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Gufic BioSciences insights

68 extracted metrics + investor summaries across FY11–FY26.

Log in — free

Shareholding Pattern

FIIs0.46%Promot.72.50%DIIs3.68%Others9.36%Public14.00%As ofJun 2026

Documents

Frequently Asked Questions about Gufic BioSciences

What does Gufic BioSciences Ltd do?
Gufic Biosciences Limited is engaged in the manufacture of pharmaceuticals, medicinal chemicals and botanical products.
Where is Gufic BioSciences Ltd (GUFICBIO) listed?
Gufic BioSciences Ltd trades as GUFICBIO on the NSE and under code 509079 on the BSE.
Which sector does Gufic BioSciences Ltd belong to?
Gufic BioSciences Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the market capitalisation of Gufic BioSciences Ltd?
Gufic BioSciences Ltd has a market capitalisation of ₹4,244 Cr, which places it in the Small Cap band.
What is the PE ratio of Gufic BioSciences Ltd?
Gufic BioSciences Ltd trades at a PE ratio of 57.99, on earnings per share of ₹8.59, against a book value of ₹66.31 per share.
What is the 52-week high and low of Gufic BioSciences Ltd?
Over the last 52 weeks Gufic BioSciences Ltd has traded between ₹268 and ₹467.8.
Does Gufic BioSciences Ltd pay dividends?
Gufic BioSciences Ltd has a dividend yield of 0.02%.
What is the Return on Equity (ROE) of Gufic BioSciences Ltd?
Gufic BioSciences Ltd reported a return on equity of 9.66%. Its debt-to-equity ratio is 0.61.

Company Information

Gufic Biosciences Limited is engaged in the manufacture of pharmaceuticals, medicinal chemicals and botanical products.

Website gufic.com
CEO Mr. Jayesh Pannalal Choksi
Employees 1,484
Listed 2004-10-19
Face Value ₹ 1
Issued Size 10,02,82,506

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/GUFICBIO.md for Gufic BioSciences Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in Healthcare → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List